India’s pharmaceutical industry occupies a unique and powerful position in global healthcare. It supplies nearly half of all generic medicines consumed in the United States and is indispensable to public health systems across the world. Yet within India, generic medicines continue to face deep scepticism from doctors and patients alike.
This contradiction raises a fundamental question:
Do Indian pharmaceutical companies adhere to identical quality norms when supplying generics to the U.S. market and the Indian market?
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
